But one side effect caught public attention: weight loss
Speaking over the companys earnings call, Srinivas Sadu, Executive Chairman Gland Pharma, said, Our GLP-1 strategy gained momentum last quarter and and this quarter th drug was launched in UK and Australia. We are aggressively increasing our GLP-1/Pen/cartridge capacity from 40 million to 140 million units, and the battery acceptance test (BAT) scheduled to be completed by September 2025, the executive chairman added
J Med Humanit
GSH has long been used in clinical practice via various routes of administration, with good therapeutic effects and safety [32,33,34]
One study in 50 patients with advanced gastric cancer receiving weekly cisplatin-based treatment reported that intravenous administration of 1.5 g/m 2 glutathione before treatment and then 600 mg intramuscularly on days two to five prevented neuropathy without affecting response to treatment (Cascinu 1995)
CPCB Registration Number: BO-12-000-12-AAFCH0247Q-24